
Srinivas Viswanathan
Assistant Professor of Medicine, Harvard Medical School · Mass General Brigham
Credentials: · · · · ·
History
Research
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Nature · 2017 · 1,640 citations
Selective blockade of microRNA processing by Lin28
Science · 2008 · First of 3 authors · 1,191 citations
Lin28 promotes transformation and is associated with advanced human malignancies
Nature Genetics · 2009 · First of 24 authors · 709 citations

17 papers
- GD
9 papers

8 papers

7 papers

7 papers

6 papers · 6 as a fellow

6 papers · 6 as a fellow

6 papers · 3 as a fellow
Grants
- 2026–2031
From Biology to Therapy: Mechanism-Informed Targeting in Translocation Renal Cell Carcinoma
National Cancer Institute · R01
Contact PI · $737.1K · Dana-Farber Cancer Inst
- 2023–2028
Probing the Role of Somatic X-Chromosome Alterations in Shaping Cancer Sex Differences
National Cancer Institute · R01
Contact PI · $2.7M · Dana-Farber Cancer Inst
- 2023–2028
National Cancer Institute · R01
Contact PI · $2M · Dana-Farber Cancer Inst
- 2023–2028
Regulation of Androgen Receptor Signaling in Prostate Cancer by Protein Arginine Methylation
National Cancer Institute · R01
Contact PI · $1.1M · Dana-Farber Cancer Inst



